Private Advisor Group LLC Has $216,000 Position in VanEck Biotech ETF (NASDAQ:BBH)

Private Advisor Group LLC lessened its holdings in VanEck Biotech ETF (NASDAQ:BBH) by 26.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,375 shares of the company’s stock after selling 500 shares during the quarter. Private Advisor Group LLC owned 0.06% of VanEck Biotech ETF worth $216,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of the business. Kovitz Investment Group Partners LLC boosted its holdings in shares of VanEck Biotech ETF by 4.6% during the 3rd quarter. Kovitz Investment Group Partners LLC now owns 3,186 shares of the company’s stock valued at $565,000 after acquiring an additional 141 shares in the last quarter. Flagship Harbor Advisors LLC raised its position in shares of VanEck Biotech ETF by 12.1% in the 4th quarter. Flagship Harbor Advisors LLC now owns 1,984 shares of the company’s stock worth $311,000 after acquiring an additional 214 shares in the last quarter. Truvestments Capital LLC bought a new position in shares of VanEck Biotech ETF in the 3rd quarter worth about $44,000. FSA Wealth Management LLC acquired a new stake in shares of VanEck Biotech ETF in the 3rd quarter valued at about $54,000. Finally, Coastline Trust Co acquired a new stake in shares of VanEck Biotech ETF in the 3rd quarter valued at about $59,000. Institutional investors and hedge funds own 32.05% of the company’s stock.

VanEck Biotech ETF Price Performance

Shares of BBH opened at $164.60 on Friday. The company has a market cap of $401.62 million, a PE ratio of 30.97 and a beta of 0.85. VanEck Biotech ETF has a one year low of $151.35 and a one year high of $183.64. The stock has a 50-day moving average of $161.88 and a 200-day moving average of $168.68.

VanEck Biotech ETF Announces Dividend

The business also recently declared a dividend, which was paid on Tuesday, December 24th. Shareholders of record on Monday, December 23rd were paid a dividend of $1.2517 per share. The ex-dividend date of this dividend was Monday, December 23rd.

VanEck Biotech ETF Profile

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.